The combined treatment of human peripheral blood mononuclear cells with thymolymphotropin and interleukin 2 increases PPD-driven T-cell proliferation and IL-2 induced cellular cytotoxicity against HIV-infected cells
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (8) , 1157-1165
- https://doi.org/10.1016/0192-0561(91)90167-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reductionAntiviral Research, 1989
- Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditionsArchiv für die gesamte Virusforschung, 1988
- The combined administration of thymomodulin and interleukin 2 reverses T-cell unresponsiveness in mice infected with Mycobacterium bovis-BCGInternational Journal of Immunopharmacology, 1988
- Thymostimulin treatment in AIDS-related complexClinical Immunology and Immunopathology, 1988
- Immunoreconstitution of T-cell impairments in asymptomatic male homosexuals by Thymic Humoral Factor (THF)International Journal of Immunopharmacology, 1987
- Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.The Journal of Experimental Medicine, 1986
- Clinical improvement and partial correction of the T cell defects of acquired immunodeficiency syndrome (AIDS) and lymphoadenopathy syndrome (LAS) by a calf thymus acid lysateEuropean Journal of Cancer and Clinical Oncology, 1986
- Low Serum Thymic Hormone Levels in Patients with Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- Thymic Dysplasia in Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983
- Selected phenotypic induction of null lymphocytes from mice with thymic and nonthymic agentsCellular Immunology, 1982